HILBRENZY Trademark
Trademark Overview
On Wednesday, March 26, 2025, a trademark application was filed for HILBRENZY with the United States Patent and Trademark Office. The USPTO has given the HILBRENZY trademark a serial number of 99104822. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, August 15, 2025. This trademark is owned by Glaxo Group Limited. The HILBRENZY trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
General Information
| Serial Number | 99104822 |
| Word Mark | HILBRENZY |
| Filing Date | Wednesday, March 26, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, August 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 26, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 26, 2025 | NEW APPLICATION ENTERED |
| Wednesday, March 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 8, 2025 | LETTER OF SUSPENSION E-MAILED |
| Friday, August 8, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, August 8, 2025 | SUSPENSION LETTER WRITTEN |
| Wednesday, March 26, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 7, 2025 | ASSIGNED TO EXAMINER |
| Thursday, August 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 14, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, August 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
